Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2014

Open Access 01-10-2014 | Research article

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade

Authors: Yoshishige Miyabe, Chie Miyabe, Yoshiko Iwai, Waka Yokoyama, Chiyoko Sekine, Kazutaka Sugimoto, Masayoshi Harigai, Masayuki Miyasaka, Nobuyuki Miyasaka, Toshihiro Nanki

Published in: Arthritis Research & Therapy | Issue 5/2014

Login to get access

Abstract

Introduction

Lysophosphatidic acid (LPA) is a bioactive lipid that binds to G protein-coupled receptors (LPA1-6). Recently, we reported that abrogation of LPA receptor 1 (LPA1) ameliorated murine collagen-induced arthritis, probably via inhibition of inflammatory cell migration, Th17 differentiation and osteoclastogenesis. In this study, we examined the importance of the LPA-LPA1 axis in cell proliferation, cytokine/chemokine production and lymphocyte transmigration in fibroblast-like synoviocytes (FLSs) obtained from the synovial tissues of rheumatoid arthritis (RA) patients.

Methods

FLSs were prepared from synovial tissues of RA patients. Expression of LPA1-6 was examined by quantitative real-time RT-PCR. Cell surface LPA1 expression was analyzed by flow cytometry. Cell proliferation was analyzed using a cell-counting kit. Production of interleukin 6 (IL-6), vascular endothelial growth factor (VEGF), chemokine?(C-C motif) ligand 2 (CCL2), metalloproteinase 3 (MMP-3) and chemokine (C-X-C motif) ligand 12 (CXCL12) was measured by enzyme-linked immunosorbent assay. Pseudoemperipolesis was evaluated using a coculture of RA FLSs and T or B cells. Cell motility was examined by scrape motility assay. Expression of adhesion molecules was determined by flow cytometry.

Results

The expression of LPA1 mRNA and cell surface LPA1 was higher in RA FLSs than in FLSs from osteoarthritis tissue. Stimulation with LPA enhanced the proliferation of RA FLSs and the production of IL-6, VEGF, CCL2 and MMP-3 by FLSs, which were suppressed by an LPA1 inhibitor (LA-01). Ki16425, another LPA1 antagonist, also suppressed IL-6 production by LPA-stimulated RA FLSs. However, the production of CXCL12 was not altered by stimulation with LPA. LPA induced the pseudoemperipolesis of T and B cells cocultured with RA FLSs, which was suppressed by LPA1 inhibition. In addition, LPA enhanced the migration of RA FLSs and expression of vascular cell adhesion molecule and intercellular adhesion molecule on RA FLSs, which were also inhibited by an LPA1 antagonist.

Conclusions

Collectively, these results indicate that LPA-LPA1 signaling contributes to the activation of RA FLSs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kinne RW, Bräuer R, Stuhlmüller B, Palombo-Kinne E, Burmester GR: Macrophages in rheumatoid arthritis. Arthritis Res. 2000, 2: 189-202. 10.1186/ar86.CrossRefPubMedCentralPubMed Kinne RW, Bräuer R, Stuhlmüller B, Palombo-Kinne E, Burmester GR: Macrophages in rheumatoid arthritis. Arthritis Res. 2000, 2: 189-202. 10.1186/ar86.CrossRefPubMedCentralPubMed
2.
go back to reference Bottini N, Firestein GS: Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013, 9: 24-33. 10.1038/nrrheum.2012.190.CrossRefPubMedCentralPubMed Bottini N, Firestein GS: Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013, 9: 24-33. 10.1038/nrrheum.2012.190.CrossRefPubMedCentralPubMed
3.
go back to reference Aoki J: Mechanisms of lysophosphatidic acid production. Semin Cell Dev Biol. 2004, 15: 477-489. 10.1016/j.semcdb.2004.05.001.CrossRefPubMed Aoki J: Mechanisms of lysophosphatidic acid production. Semin Cell Dev Biol. 2004, 15: 477-489. 10.1016/j.semcdb.2004.05.001.CrossRefPubMed
4.
go back to reference Kawagoe H, Stracke ML, Nakamura H, Sano K: Expression and transcriptional regulation of the PD-I?/autotaxin gene in neuroblastoma. Cancer Res. 1997, 57: 2516-2521.PubMed Kawagoe H, Stracke ML, Nakamura H, Sano K: Expression and transcriptional regulation of the PD-I?/autotaxin gene in neuroblastoma. Cancer Res. 1997, 57: 2516-2521.PubMed
5.
go back to reference Yang SY, Lee J, Park CG, Kim S, Hong S, Chung HC, Min SK, Han JW, Lee HW, Lee HY: Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis. 2002, 19: 603-608. 10.1023/A:1020950420196.CrossRefPubMed Yang SY, Lee J, Park CG, Kim S, Hong S, Chung HC, Min SK, Han JW, Lee HW, Lee HY: Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis. 2002, 19: 603-608. 10.1023/A:1020950420196.CrossRefPubMed
6.
go back to reference Stassar MJ, Devitt G, Brosius M, Rinnab L, Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider A, Zöller M: Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer. 2001, 85: 1372-1382. 10.1054/bjoc.2001.2074.CrossRefPubMedCentralPubMed Stassar MJ, Devitt G, Brosius M, Rinnab L, Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider A, Zöller M: Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer. 2001, 85: 1372-1382. 10.1054/bjoc.2001.2074.CrossRefPubMedCentralPubMed
7.
go back to reference Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H: Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol. 2002, 158: 227-233. 10.1083/jcb.200204026.CrossRefPubMedCentralPubMed Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H: Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol. 2002, 158: 227-233. 10.1083/jcb.200204026.CrossRefPubMedCentralPubMed
8.
go back to reference Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC, Cui X, Murrow G, Coombes K, Muller W, Hung MC, Perou CM, Lee AV, Fang X, Milles GB: Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. 2009, 15: 539-550. 10.1016/j.ccr.2009.03.027. A published erratum appears in Cancer Cell 2009, 16:172CrossRefPubMedCentralPubMed Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC, Cui X, Murrow G, Coombes K, Muller W, Hung MC, Perou CM, Lee AV, Fang X, Milles GB: Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. 2009, 15: 539-550. 10.1016/j.ccr.2009.03.027. A published erratum appears in Cancer Cell 2009, 16:172CrossRefPubMedCentralPubMed
9.
go back to reference Masuda A, Nakamura K, Izutsu K, Igarashi K, Ohkawa R, Jona M, Higashi K, Yokota H, Okudaira S, Kishimoto T, Watanabe T, Koike Y, Ikeda H, Kozai Y, Kurokawa M, Aoki J, Yatomi Y: Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol. 2008, 143: 60-70. 10.1111/j.1365-2141.2008.07325.x.CrossRefPubMed Masuda A, Nakamura K, Izutsu K, Igarashi K, Ohkawa R, Jona M, Higashi K, Yokota H, Okudaira S, Kishimoto T, Watanabe T, Koike Y, Ikeda H, Kozai Y, Kurokawa M, Aoki J, Yatomi Y: Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol. 2008, 143: 60-70. 10.1111/j.1365-2141.2008.07325.x.CrossRefPubMed
10.
go back to reference Schleicher SM, Thotala DK, Linkous AG, Hu R, Leahy KM, Yazlovitskaya EM, Hallahan DE: Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature. PLoS One. 2011, 6: e22182-10.1371/journal.pone.0022182.CrossRefPubMedCentralPubMed Schleicher SM, Thotala DK, Linkous AG, Hu R, Leahy KM, Yazlovitskaya EM, Hallahan DE: Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature. PLoS One. 2011, 6: e22182-10.1371/journal.pone.0022182.CrossRefPubMedCentralPubMed
11.
go back to reference Houben AJ, Moolenaar WH: Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev. 2011, 30: 557-565. 10.1007/s10555-011-9319-7.CrossRefPubMed Houben AJ, Moolenaar WH: Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev. 2011, 30: 557-565. 10.1007/s10555-011-9319-7.CrossRefPubMed
12.
go back to reference Nikitopoulou I, Oikonomou N, Karouzakis E, Sevastou I, Nikolaidou-Katsaridou N, Zhao Z, Mersinias V, Armaka M, Xu Y, Masu M, Milles GB, Gay S, Kollias G, Aidinis V: Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. J Exp Med. 2012, 209: 925-933. 10.1084/jem.20112012.CrossRefPubMedCentralPubMed Nikitopoulou I, Oikonomou N, Karouzakis E, Sevastou I, Nikolaidou-Katsaridou N, Zhao Z, Mersinias V, Armaka M, Xu Y, Masu M, Milles GB, Gay S, Kollias G, Aidinis V: Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. J Exp Med. 2012, 209: 925-933. 10.1084/jem.20112012.CrossRefPubMedCentralPubMed
13.
go back to reference Kehlen A, Lauterbach R, Santos AN, Thiele K, Kabisch U, Weber E, Riemann D, Langner J: IL-1?- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol. 2001, 123: 147-154. 10.1046/j.1365-2249.2001.01432.x.CrossRefPubMedCentralPubMed Kehlen A, Lauterbach R, Santos AN, Thiele K, Kabisch U, Weber E, Riemann D, Langner J: IL-1?- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol. 2001, 123: 147-154. 10.1046/j.1365-2249.2001.01432.x.CrossRefPubMedCentralPubMed
14.
go back to reference Bourgoin SG, Zhao C: Autotaxin and lysophospholipids in rheumatoid arthritis. Curr Opin Investig Drugs. 2010, 11: 515-526.PubMed Bourgoin SG, Zhao C: Autotaxin and lysophospholipids in rheumatoid arthritis. Curr Opin Investig Drugs. 2010, 11: 515-526.PubMed
15.
go back to reference Miyabe Y, Miyabe C, Iwai Y, Takayasu A, Fukuda S, Yokoyama W, Nagai J, Jona M, Tokuhara Y, Ohkawa R, Albers HM, Ovaa H, Aoki J, Chun J, Yatomi Y, Ueda H, Miyasaka M, Miyasaka N, Nanki T: Necessity of lysophosphatidic acid receptor 1 for development of arthritis. Arthritis Rheum. 2013, 65: 2037-2047. 10.1002/art.37991.CrossRefPubMed Miyabe Y, Miyabe C, Iwai Y, Takayasu A, Fukuda S, Yokoyama W, Nagai J, Jona M, Tokuhara Y, Ohkawa R, Albers HM, Ovaa H, Aoki J, Chun J, Yatomi Y, Ueda H, Miyasaka M, Miyasaka N, Nanki T: Necessity of lysophosphatidic acid receptor 1 for development of arthritis. Arthritis Rheum. 2013, 65: 2037-2047. 10.1002/art.37991.CrossRefPubMed
16.
go back to reference Cader MZ, Filer A, Hazlehurst J, de Pablo P, Buckley CD, Raza K: Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis. 2011, 70: 949-955. 10.1136/ard.2010.143560.CrossRefPubMed Cader MZ, Filer A, Hazlehurst J, de Pablo P, Buckley CD, Raza K: Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis. 2011, 70: 949-955. 10.1136/ard.2010.143560.CrossRefPubMed
17.
go back to reference Kaneko K, Miyabe Y, Takayasu A, Fukuda S, Miyabe C, Ebisawa M, Yokoyama W, Watanabe K, Imai T, Muramoto K, Terashima Y, Sugihara T, Matsushima K, Miyasaka N, Nanki T: Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res Ther. 2011, 13: R158-10.1186/ar3475.CrossRefPubMedCentralPubMed Kaneko K, Miyabe Y, Takayasu A, Fukuda S, Miyabe C, Ebisawa M, Yokoyama W, Watanabe K, Imai T, Muramoto K, Terashima Y, Sugihara T, Matsushima K, Miyasaka N, Nanki T: Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res Ther. 2011, 13: R158-10.1186/ar3475.CrossRefPubMedCentralPubMed
18.
go back to reference Watanabe K, Penfold ME, Matsuda A, Ohyanagi N, Kaneko K, Miyabe Y, Matsumoto K, Schall TJ, Miyasaka N, Nanki T: Pathogenic role of CXCR7 in rheumatoid arthritis. Arthritis Rheum. 2010, 62: 3211-3220. 10.1002/art.27650.CrossRefPubMed Watanabe K, Penfold ME, Matsuda A, Ohyanagi N, Kaneko K, Miyabe Y, Matsumoto K, Schall TJ, Miyasaka N, Nanki T: Pathogenic role of CXCR7 in rheumatoid arthritis. Arthritis Rheum. 2010, 62: 3211-3220. 10.1002/art.27650.CrossRefPubMed
20.
go back to reference Ishii S, Noguchi K, Yanagida K: Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat. 2009, 89: 57-65. 10.1016/j.prostaglandins.2009.06.001.CrossRefPubMed Ishii S, Noguchi K, Yanagida K: Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat. 2009, 89: 57-65. 10.1016/j.prostaglandins.2009.06.001.CrossRefPubMed
21.
go back to reference Bradfield PF, Amft N, Vernon-Wilson E, Exley AE, Parsonage G, Rainger GE, Nash GB, Thomas AM, Simmons DL, Salmon M, Buckley CD: Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum. 2003, 48: 2472-2482. 10.1002/art.11219.CrossRefPubMed Bradfield PF, Amft N, Vernon-Wilson E, Exley AE, Parsonage G, Rainger GE, Nash GB, Thomas AM, Simmons DL, Salmon M, Buckley CD: Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum. 2003, 48: 2472-2482. 10.1002/art.11219.CrossRefPubMed
22.
go back to reference Zhao C, Fernandes MJ, Prestwich GD, Turgeon M, Di Battista J, Clair T, Poubelle PE, Bourgoin SG: Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?. Mol Pharmacol. 2008, 73: 587-600. 10.1124/mol.107.038216.CrossRefPubMed Zhao C, Fernandes MJ, Prestwich GD, Turgeon M, Di Battista J, Clair T, Poubelle PE, Bourgoin SG: Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?. Mol Pharmacol. 2008, 73: 587-600. 10.1124/mol.107.038216.CrossRefPubMed
23.
go back to reference Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell’Aquila M, Kipps TJ: Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood. 2000, 96: 2655-2663.PubMed Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell’Aquila M, Kipps TJ: Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood. 2000, 96: 2655-2663.PubMed
24.
go back to reference Burger JA, Zvaifler NJ, Tsukada N, Firestein GS, Kipps TJ: Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1) -dependent mechanism. J Clin Invest. 2001, 107: 305-315. 10.1172/JCI11092.CrossRefPubMedCentralPubMed Burger JA, Zvaifler NJ, Tsukada N, Firestein GS, Kipps TJ: Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1) -dependent mechanism. J Clin Invest. 2001, 107: 305-315. 10.1172/JCI11092.CrossRefPubMedCentralPubMed
25.
go back to reference Kanda H, Newton R, Klein R, Morita Y, Gunn MD, Rosen SD: Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol. 2008, 9: 415-423. 10.1038/ni1573.CrossRefPubMedCentralPubMed Kanda H, Newton R, Klein R, Morita Y, Gunn MD, Rosen SD: Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol. 2008, 9: 415-423. 10.1038/ni1573.CrossRefPubMedCentralPubMed
26.
go back to reference Zhang Y, Chen YC, Krummel MF, Rosen SD: Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells. J Immunol. 2012, 189: 3914-3924. 10.4049/jimmunol.1201604.CrossRefPubMedCentralPubMed Zhang Y, Chen YC, Krummel MF, Rosen SD: Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells. J Immunol. 2012, 189: 3914-3924. 10.4049/jimmunol.1201604.CrossRefPubMedCentralPubMed
27.
go back to reference Bai Z, Cai L, Umemoto E, Takeda A, Tohya K, Komai Y, Veeraveedu PT, Hata E, Sugiura Y, Kubo A, Suematsu M, Hayasaka H, Okudaira S, Aoki J, Tanaka T, Albers HM, Ovaa H, Miyasaka M: Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis. J Immunol. 2013, 190: 2036-2048. 10.4049/jimmunol.1202025.CrossRefPubMed Bai Z, Cai L, Umemoto E, Takeda A, Tohya K, Komai Y, Veeraveedu PT, Hata E, Sugiura Y, Kubo A, Suematsu M, Hayasaka H, Okudaira S, Aoki J, Tanaka T, Albers HM, Ovaa H, Miyasaka M: Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis. J Immunol. 2013, 190: 2036-2048. 10.4049/jimmunol.1202025.CrossRefPubMed
28.
go back to reference Orosa B, González A, Mera A, Gómez-Reino JJ, Conde C: Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis. Arthritis Rheum. 2012, 64: 2460-2470. 10.1002/art.34443.CrossRefPubMed Orosa B, González A, Mera A, Gómez-Reino JJ, Conde C: Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis. Arthritis Rheum. 2012, 64: 2460-2470. 10.1002/art.34443.CrossRefPubMed
Metadata
Title
Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade
Authors
Yoshishige Miyabe
Chie Miyabe
Yoshiko Iwai
Waka Yokoyama
Chiyoko Sekine
Kazutaka Sugimoto
Masayoshi Harigai
Masayuki Miyasaka
Nobuyuki Miyasaka
Toshihiro Nanki
Publication date
01-10-2014
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2014
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-014-0461-9

Other articles of this Issue 5/2014

Arthritis Research & Therapy 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.